Are Current Serum and Plasma Ferritin Cut-offs for Iron Deficiency and Overload Accurate and Reflecting Iron Status? A Systematic Review

Archives of Medical Research

Volumn 49, Issue 6, 2018, Pages 405-417

  Garcia Casal, Maria Nieves ^a   Pasricha, Sant Rayn ^b   Martinez, Ricardo X ^a   Lopez Perez, Lucero ^a   Peña Rosas, Juan Pablo ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bone marrow; Cut offs; Ferritin; Iron deficiency; Liver biopsy; Risk of iron overload

Indexed keywords

FERRITIN; IRON; BIOLOGICAL MARKER;

BONE MARROW BIOPSY; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON DEPLETION; IRON OVERLOAD; LIVER BIOPSY; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; REVIEW; STANDARD; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; ADULT; BLOOD; FEMALE; IRON DEFICIENCY ANEMIA; MALE;

ADULT; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; MALE; REFERENCE STANDARDS;

EID: 85058488308     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2018.12.005     Document Type: Review

References (117)

1. Tussing-Humphreys, L., Pusatcioglu, C., Nemeth, E., et al. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J Acad Nutr Diet 112 (2012), 391–400.
2. Low, M., Speedy, J., Styles, C.E., et al. Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev, 4, 2016, CD009747.
3. Verdon, F., Burnand, B., Stubi, C.L., et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 326 (2003), 1124–1127.
4. Pasricha, S.R., Low, M., Thompson, J., et al. Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis. J Nutr 144 (2014), 906–914.
5. Li, R., Chen, X., Yan, H., et al. Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China. Am J Clin Nutr 59 (1994), 908–913.
6. Lozoff, B., Iron deficiency and child development. Food Nutr Bull 28:4 Suppl (2007), S560–S571.
7. Georgieff, M., Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev 69:Suppl 1 (2011), S43–S48.
8. Camaschella, C., Iron-deficiency anemia. N Engl J Med 372 (2015), 1832–1843.
9. Papagiannakis, P., Michalopoulos, C., Papalexi, F., et al. The role of Helicobacter pylori infection in hematological disorders. Eur J Intern Med 24 (2013), 685–690.
10. Spencer, B., Blood donor iron status: are we bleeding them dry?. Curr Opin Hematol 20 (2013), 533–539.
11. Brissot, P., Le Lan, C., Troadec, M.B., et al. Diagnosis and treatment of HFE-haemochromatosis. Beaumont, C., Béris, P., Beuzard, Y., Brugnara, C., (eds.) Disorders of erythropoiesis, erythrocytes and iron metabolism, 2009, European School of Haematology, Paris, France.
12. Piga, A., Roggero, S., Longo, F., et al. Chapter 25: Evaluation and treatment of secondary iron overload. Beaumont, C., Béris, P., Beuzard, Y., Brugnara, C., (eds.) Disorders of erythrocytes, erythropoiesis and iron metabolism, 2009, European School of Haematology, Paris, France.
13. Bacon, B.R., Adams, P.C., Kowdley, K.V., et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54 (2011), 328–343.
14. Baer, D.M., Simons, J.L., Staples, R.L., et al. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 98 (1995), 464–468.
15. Phatak, P.D., Sham, R.L., Raubertas, R.F., et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 129 (1998), 954–961.
16. Weatherall, D.J., The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res 134 (2011), 493–497.
17. Lorcerie, B., Audia, S., Samson, M., et al. Diagnosis of hyperferritinemia in routine clinical practice. Presse Med 46:12 Pt 2 (2017), e329–e338.
18. Daru, J., Colman, K., Stanworth, S.J., et al. Serum ferritin as an indicator of iron status: what do we need to know?. Am J Clin Nutr 106:Suppl 6 (2017), 1634S–1639S.
19. World Health Organization, Preventing and controlling anaemia through primary health care: a guide for health administrators and programme managers. 1989, World Health Organization, Geneva Available from http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9241542497.pdf.
20. World Health Organization, Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. 2011, World Health Organization, Geneva (WHO/NMH/NHD/MNM/11.2). Available from http://www.who.int/vmnis/indicators/serum_ferritin.pdf. (Accessed 28 November 2018)
21. Garcia-Casal, M.N., Peña-Rosas, J.P., Pasricha, S.R., Rethinking ferritin cutoffs for iron deficiency and overload. Lancet Haematol 1 (2014), e92–e94.
22. Garcia-Casal, M.N., Pasricha, S.-R., Martinez, R.X., et al. Serum or plasma ferritin concentration as an index of iron deficiency and overload. Cochrane Database Syst Rev, 7, 2015, CD011817.
23. Beutler, E., Robson, M.J., Buttenwieser, E., A comparison of the plasma iron, iron-binding capacity, sternal marrow iron and other methods in the clinical evaluation of iron stores. Ann Intern Med 48 (1958), 60–82.
24. Rao, P.S., Khandelia, B., Assessment of iron stores in bone marrow using an intensive grading method. Indian J Hematol Blood Transf 29 (2013), 370–371.
25. Riley, R., Williams, D., Ross, M., et al. Bone marrow aspirate and biopsy II. Interpretation of the bone marrow aspirate and biopsy. J Clin Lab Anal 23 (2009), 259–309.
26. Angelucci, E., Brittenham, G.M., McLaren, C.E., et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343 (2000), 327–331.
27. Barry, M., Liver iron co0ncentration, stainable iron, and total body storage iron. Gut 15 (1974), 411–415.
28. Wood, J.C., Guidelines for quantifying iron overload. Hematology Am Soc Hematol Educ Program 2014 (2014), 210–215.
29. Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Med 6 (2009), 1–28.
30. Hallberg, L., Bengtsson, C., Lapidus, L., et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol 85 (1993), 787–798.
31. Hanif, E., Ayyub, M., Anwar, M., et al. Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders. J Pak Med Assoc 55 (2005), 13–16.
32. Jacobs, A., Miller, F., Worwood, M., et al. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J 4 (1972), 206–208.
33. Jacobs, P., Dommisse, J., The plasma ferritin level as a reliable index of body iron stores following intravenous iron dextran. J Med 13 (1982), 309–321.
34. Jonker, F., Boele van Hensbroek, M., Leenstra, T., et al. Conventional and novel peripheral blood iron markers compared against bone marrow in Malawian children. J Clin Pathol 67 (2014), 717–723.
35. Leyland, M.J., Ganguli, P.C., Blower, D., et al. Immunoradiometric assay for ferritin in human serum. Scand J Haematol 14 (1975), 385–392.
36. Lipschitz, D.A., Cook, J.D., Finch, C.A., A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290 (1974), 1213–1216.
37. Milman, N., Bangsboll, S., Strandberg Pedersen, N., et al. Serum ferritin in non-dialysis patients with chronic renal failure: Relation to bone marrow iron stores. Scand J Haematol 30 (1983), 337–344.
38. Puolakka, J., Jänne, O., Pakarinen, A., et al. Serum ferritin as a measure of iron stores during and after normal pregnancy with and without iron supplements. Acta Obstet Gynecol Scand 95:Suppl (1980), 43–51.
39. Sorbie, J., Valberg, L.S., Corbett, W.E., et al. Serum ferritin, cobalt excretion and body iron status. Can Med Assoc J 112 (1975), 1173–1178.
40. Meira, D.G., Lorand-Metze, I., Toro, A.D.C., et al. Bone marrow features in children with HIV infection and peripheral blood cytopenias. J Trop Pediatr 51 (2005), 114–119.
41. van den Broek, N.R., Letsky, E.A., White, S.A., et al. Iron status in pregnant women: which measurements are valid?. Br J Haematol 103 (1998), 817–824.
42. Oluboyede, O.A., Iron studies in pregnant and non-pregnant women with haemoglobin SS or SC disease. Br J Obstet Gynaecol 87 (1980), 989–996.
43. Rao, K.R., Patel, A.R., McGinnis, P., et al. Iron stores in adults with sickle cell anemia. J Lab Clin Med 103 (1984), 792–797.
44. Ruivard, M., Boursiac, M., Mareynat, G., et al. Ratio serum transferrin receptor/serum ferritin in the diagnosis of iron deficiency [Diagnostic de la carence en fer: Evaluation du rapport recepteur soluble de la transferrine/ferritine]. Rev Med Interne 21 (2000), 837–843.
45. Solomon, L.R., Hillman, R.S., Finch, C.A., Serum ferritin in refractory anemias. Acta Haematol 66 (1981), 1–5.
46. Kim, S.S., Park, W., Bae, S.K., et al. The usefulness of serum transferrin receptor in anemia with rheumatoid arthritis: comparison with bone marrow iron store. J Kor Rheum Assoc 7 (2000), 360–369.
47. Hansen, T.M., Hansen, N.E., Birgens, H.S., et al. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 12 (1983), 353–359.
48. Mulherin, D., Skelly, M., Saunders, A., et al. The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures. J Rheumatol 23 (1996), 237–240.
49. Nielsen, O.J., Andersen, L.S., Ludwigsen, E., et al. Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis 49 (1990), 349–353.
50. Porter, D.R., Sturrock, R.D., Capell, H.A., The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis. Clin Exp Rheumatol 12 (1994), 179–182.
51. Ravindran, V., Jain, S., Mathur, D.S., The differentiation of anaemia in rheumatoid arthritis: parameters of iron-deficiency in an Indian rheumatoid arthritis population. Rheumatol Int 28 (2008), 507–511.
52. Shroff, K., Gaiha, M., Singh, T., et al. Iron status in patients of rheumatoid arthritis with special reference to serum ferritin levels. J Assoc Physicians India 39 (1991), 675–677.
53. Smith, R.J., Davis, P., Thomson, A.B., et al. Serum ferritin levels in anemia of rheumatoid arthritis. J Rheumatol 4 (1977), 389–392.
54. Balaban, E.P., Sheehan, R.G., Demian, S.E., et al. Evaluation of bone marrow iron stores in anemia associated with chronic disease: a comparative study of serum and red cell ferritin. Am J Hematol 42 (1993), 177–181.
55. Intragumtornchai, T., Rojnukkarin, P., Swasdikul, D., et al. The role of serum ferritin in the diagnosis of iron deficiency anaemia in patients with liver cirrhosis. J Intern Med 243 (1998), 233–241.
56. Isa, L., Jean, G., Silvani, A., et al. Evaluation of iron stores in patients with alcoholic liver disease: role of red cell ferritin. Acta Haematol 80 (1988), 85–88.
57. Kalantar-Zadeh, K., Höffken, B., Wünsch, H., et al. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 26 (1995), 292–299.
58. Krause, J.R., Stolc, V., Serum ferritin and bone marrow biopsy iron stores. II. Correlation with low serum iron and Fe/TIBC ratio less than 15%. Am J Clin Pathol 74 (1980), 461–464.
59. Nelson, R., Chawla, M., Connolly, P., et al. Ferritin as an index of bone marrow iron stores. South Med J 71 (1978), 1482–1484.
60. Ali, M., Luxton, A., Walker, W., Serum ferritin concentration and bone marrow iron stores: a prospective study. Can Med Assoc J 118 (1978), 945–946.
61. Harju, E., Pakarinen, A., Larmi, T., A comparison between serum ferritin concentration and the amount of bone marrow stainable iron. Scand J Clin Lab Invest 44 (1984), 555–556.
62. Kotru, M., Rusia, U., Sikka, M., et al. Evaluation of serum ferritin in screening for iron deficiency in tuberculosis. Ann Hematol 83 (2004), 95–100.
63. Mast, A.E., Blinder, M.A., Gronowski, A.M., et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 44 (1998), 45–51.
64. Mazza, J., Barr, R.M., McDonald, J.W., et al. Usefulness of the serum ferritin concentration in the detection of iron deficiency in a general hospital. Can Med Assoc J 119 (1978), 884–886.
65. Means, R.T.J., Allen, J., Sears, D.A., et al. Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients. Clin Lab Haematol 21 (1999), 161–167.
66. Punnonen, K., Irjala, K., Rajamäki, A., Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. Eur J Haematol 60 (1998), 135–137.
67. Witte, D.L., Angstadt, D.S., Davis, S.H., et al. Predicting bone marrow iron stores in anemic patients in a community hospital using ferritin and erythrocyte sedimentation rate. Am J Clin Pathol 90 (1988), 85–87.
68. Baillie, F.J., Morrison, A.E., Fergus, I., Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 25 (2003), 353–357.
69. Lindstedt, G., Lundberg, P.A., Bjorn-Rasmussen, E., et al. Serum-ferritin and iron-deficiency anaemia in hospital patients. Lancet 1 (1980), 205–206.
70. Nanas, J.N., Matsouka, C., Karageorgopoulos, D., et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48 (2006), 2485–2489.
71. Punnonen, K., Irjala, K., Rajamäki, A., Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 40 (1994), 774–776.
72. Punnonen, K., Irjala, K., Rajamäki, A., Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997), 1052–1057.
73. van Zeben, D., Bieger, R., van Wermeskerken, R.K., et al. Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol 44 (1990), 106–109.
74. Joosten, E., Van Loon, R., Billen, J., et al. Serum transferrin receptor in the evaluation of the iron status in elderly hospitalized patients with anemia. Am J Hematol 69 (2002), 1–6.
75. Karlsson, T., Mass spectrometry evaluation of the hepcidin-25 assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients. Eur J Haematol 95 (2015), 467–471.
76. Kis, A.M., Carnes, M., Detecting iron deficiency in anemic patients with concomitant medical problems. J Gen Intern Med 13 (1998), 455–461.
77. Sharma, J.C., Roy, S.N., Value of serum ferritin as an index of iron deficiency in elderly anaemic patients. Age Ageing 13 (1984), 248–250.
78. van Tellingen, A., Kuenen, J.C., de Kieviet, W., et al. Iron deficiency anaemia in hospitalised patients: value of various laboratory parameters. Differentiation between IDA and ACD. Neth J Med 59 (2001), 270–279.
79. Halliday, J.W., Russo, A.M., Cowlishaw, J.L., et al. Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families. Lancet 2 (1977), 621–624.
80. Holmström, P., Marmur, J., Eggertsen, G., et al. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51 (2002), 723–730.
81. Jensen, P.D., Peterslund, N.A., Poulsen, J.H., et al. The effect of iron overload and iron reductive treatment on the serum concentration of carbohydrate-deficient transferrin. Br J Haematol 88 (1994), 56–63.
82. Kaltwasser, J.P., Gottschalk, R., Schalk, K.P., et al. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 74 (1990), 360–363.
83. Lawrence, S.P., Caminer, S.J., Yavorski, R.T., et al. Correlation of liver density by magnetic resonance imaging and hepatic iron levels. A noninvasive means to exclude homozygous hemochromatosis. J Clin Gastroenterol 23 (1996), 113–117.
84. Leggett, B.A., Halliday, J.W., Brown, N.N., et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74 (1990), 525–530.
85. Lim, E.M., Rossi, E., De Boer, W.B., et al. Hepatic iron loading in patients with compound heterozygous HFE mutations. Liver Int 24 (2004), 631–636.
86. Lombard, M., Bomford, A., Hynes, M., et al. Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology 9 (1989), 1–5.
87. Macfarlane, J.D., Vreugdenhil, G.R., Doornbos, J., et al. Idiopathic haemochromatosis: magnetic resonance signal intensity ratios permit non-invasive diagnosis of low levels of iron overload. Neth J Med 47 (1995), 49–53.
88. Olynyk, J.K., Cullen, D.J., Aquilia, S., et al. A population-based study of the clinical expression of the hemochromatosis gene. Magn Reson Imaging 341 (1999), 718–724.
89. Ortega, L., Ladero, J.M., Carreras, M.P., et al. A computer-assisted morphometric quantitative analysis of iron overload in liver biopsies. A comparison with histological and biochemical methods. Pathol Res Pract 201 (2005), 673–675.
90. Pietrangelo, A., Montosi, G., Totaro, A., et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 341 (1999), 725–732.
91. Rowe, J.W., Wands, J.R., Mezey, E., et al. amilial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine 56 (1977), 197–211.
92. Schöniger-Hekele, M., Müller, C., Polli, C., et al. Liver pathology in compound heterozygous patients for hemochromatosis mutations. Liver 22 (2002), 295–301.
93. Sham, R.L., Ou, C.Y., Cappuccio, J., et al. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Mol Dis 23 (1997), 314–320.
94. Smith, B.N., Kantrowitz, W., Grace, N.D., et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor?. Hepatology 25 (1997), 1439–1446.
95. Summers, K.M., Halliday, J.W., Powell, L.W., Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 12 (1990), 20–25.
96. Thomsen, C., Wiggers, P., Ring-Larsen, H., et al. Identification of patients with hereditary haemochromatosis by Magnetic Resonance Imaging and spectroscopic relaxation time measurements. Magn Reson Imaging 10 (1992), 867–879.
97. Wands, J.R., Rowe, J.A., Mezey, S.E., et al. Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med 294 (1976), 302–305.
98. Chapman, R.W., Morgan, M.Y., Laulicht, M., et al. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 27 (1982), 909–916.
99. Harada, M., Hirai, K., Sakisaka, S., et al. Comparative study of magnetic resonance imaging, computed tomography and histology in the assessment of liver iron overload. Intern Med 31 (1992), 180–184.
100. Niederau, C., Niederau, C.M., Lange, S., et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med 128 (1998), 337–545.
101. Pascoe, A., Kerlin, P., Steadman, C., et al. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut 45 (1999), 301–305.
102. Sebastiani, G., Tempesta, D., Alberti, A., Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat 19 (2012), 170–176.
103. Villeneuve, J.P., Bilodeau, M., Lepage, R., et al. Variability in hepatic iron concentration measurement from needle-biopsy specimens. Hepatology 25 (1996), 172–177.
104. Walsh, A., Dixon, J.L., Ramm, G.A., et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol 4 (2006), 1403–1410.
105. Guyader, D., Thirouard, A.S., Erdtmann, L., et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol 46 (2007), 587–595.
106. Sebastiani, G., Vario, A., Ferrari, A., et al. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat 13 (2006), 199–205.
107. Thorburn, D., Curry, G., Spooner, R., et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50 (2002), 248–252.
108. Maliken, B.D., Avrin, W.F., Nelson, J.E., et al. Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin. Ann Hepatol 11 (2012), 77–84.
109. Guyatt, G.H., Patterson, C., Ali, M., et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med 88 (1990), 205–209.
110. Namaste, S., Rohner, F., Huang, J., et al. Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr 106:Suppl 1 (2017), 359S–371S.
111. Engle-Stone, R., Nankap, M., Ndjebayi, A.O., et al. Plasma ferritin and soluble transferrin receptor concentrations and body iron stores identify similar risk factors for iron deficiency but result in different estimates of the national prevalence of iron deficiency and iron-deficiency anemia among women and children in Cameroon. J Nutr 143 (2012), 369–377.
112. Righetti, A.A., Wegmuller, R., Glinz, D., et al. Effects of inflammation and Plasmodium falciparum infection on soluble transferrin receptor and plasma ferritin concentration in different age groups: a prospective longitudinal study in Cote d'Ivoire. Am J Clin Nutr 97 (2013), 1364–1374.
113. Thurnham, D.I., McCabe, L.D., Haldar, S., et al. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr 92 (2011), 546–555.
114. Thurnham, D.I., Northrop-Clewes, C.A., Knowles, J., The use of adjustment factors to address the impact of inflammation on vitamin A and iron status in humans. J Nutr 145 (2015), 1137S–1343S.
115. Bain, B., Bailey, K., Pitfalls in obtaining and interpreting bone marrow aspirates: to err is human. J Clin Pathol 64 (2011), 373–379.
116. World Health Organization, Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. 2001, World Health Organization, Geneva (WHO/NHD/01.3); Available from http://apps.who.int/iris/bitstream/10665/66914/1/WHO_NHD_01.3.pdf?ua = 1.
117. World Health Organization, Nutritional anaemias: tools for effective prevention and control. 2017, World Health Organization http://www.who.int/iris/handle/10665/259425. License: CC BY-NC-SA 3.0 IGO. (Accessed 12 May 2018)